for Journals by Title or ISSN
for Articles by Keywords
Followed Journals
Journal you Follow: 0
Sign Up to follow journals, search in your chosen journals and, optionally, receive Email Alerts when new issues of your Followed Journals are published.
Already have an account? Sign In to see the journals you follow.
Journal Cover   The Tan Sheet
  [0 followers]  Follow
   Full-text available via subscription Subscription journal
   ISSN (Print) 1530-1206
   Published by Informa plc Homepage  [16 journals]
  • FDA Labeling Guidance Stresses Genetically Engineered Is Not 'GMO' And
           ‘Free’ Is Rare
    • Abstract: FDA provides guidance for firms to advertise whether their nutritional supplements and other food products contain genetically engineered ingredients. The recommendations, part of a package of guidances about GE product approvals and labeling, provide samples of claims not likely to mislead consumers.
      PubDate: Fri, 20 Nov 2015 00:05:01 -050
  • Industry Roundup: Spiked Imports, GMP Warning, GelStat CEO
    • Abstract: FDA notes more spiked imports; Life Support needs relief; GelStat turns to turnaround veteran.
      PubDate: Fri, 20 Nov 2015 00:00:00 -050
  • P&G Leaves Divesting Out Of Value-Building Tool Box – CFO
    • Abstract: P&G CFO Jon Moeller says splitting up or spinning off business units is a relevant question, but is a short-term approach while the firm is focused on long-term value building through innovation. During an investor conference, he also discusses plans to boost promotional spending.
      PubDate: Thu, 19 Nov 2015 00:05:02 -050
  • Federal Sweep On Spiked Supplements, Disease Claims Nets 40 Cases
    • Abstract: A deputy assistant attorney general clarifies that ongoing investigations target “unlawful makers and marketers of dietary supplements,” but DoJ and other agencies broadly warn the entire industry about the potential for additional criminal cases as well as civil complaints.
      PubDate: Wed, 18 Nov 2015 00:05:00 -050
  • Califf Deftly Defuses Sunscreen, DSHEA Probes In Confirmation Hearing
    • Abstract: FDA commissioner nominee Robert Califf suggests adequate evidence is key to moving sunscreen TEAs through FDA’s evaluation process during his Senate confirmation hearing. He just as smoothly handled HELP Committee members’ questions about DSEHA and FDA rulemaking.
      PubDate: Wed, 18 Nov 2015 00:00:03 -050
  • OTC Acetaminophen Label Guidance Clarifies Ingredient Specifics In Liver
    • Abstract: FDA allows marketers of acetaminophen-containing OTC products to use an alternative liver warning, according to an updated guidance. The change from the draft, which aligns with a request by CHPA, separates maximum dosage for the ingredient from the dosage included in a certain product.
      PubDate: Tue, 17 Nov 2015 00:05:01 -050
  • Synergy CHC Acquires UrgentRx Ticket To OTC Market
    • Abstract: Synergy also acquires Australian brand Flat Tummy Tea. Both deals partly are financed through a $5.5m loan from Knight Therapeutics, a Canadian firm that in January also provided Synergy with a $6m loan to acquire the Focusfactor dietary supplement brand.
      PubDate: Tue, 17 Nov 2015 00:00:03 -050
  • Reformulated Zicam Nasal Swabs Return Matrixx To Top
           Sales Category
    • Abstract: Matrixx Initiatives re-launches Zicam Cold Remedy Nasal Swabs with “plant-based ingredients” replacing the original product’s zinc gluconate. Consumer trust in the Zicam brand prompted the reformulation and re-launch, says CEO M’lou Walker.
      PubDate: Mon, 16 Nov 2015 00:09:00 -050
  • USANA My Smart Foods Let Customers Control
    • Abstract: The weight loss and nutritional products direct seller also extends its business to Indonesia on Nov. 16. MySmartFoods users “customize or personalize their products based upon their individual needs,” says CEO Kevin Guest.
      PubDate: Mon, 16 Nov 2015 00:05:00 -050
  • Perrigo Stands Alone At Top Of OTC Private Label Market And To Hunt For
           More Deals
    • Abstract: The failure of Mylan’s tender closes a bitter seven-month long battle marked by Perrigo litigation filed to block the tender and by orders from Irish securities regulators for Perrigo to correct or clarify its comments about Mylan’s offer. CEO Joseph Papa looks to Europe to add more consumer product business.
      PubDate: Mon, 16 Nov 2015 00:05:00 -050
  • Weekly Trademark Review Nov. 10, 2015
    • Abstract: OTC drug, personal care product and nutritional supplement trademark filings compiled by “The Tan Sheet” from Official Gazette of the U.S. Patent and Trademark Office, Class 3 – Cosmetics and Cleaning Preps; and Class 5 – Pharmaceuticals.
      PubDate: Mon, 16 Nov 2015 00:03:36 -050
  • Industry Roundup: Inaffit Recall, UK Cold/Flu Claim Canned,
           Earth’s Best Repackaged
    • Abstract: Boots ‘cold and flu’ claim booted in UK; $16M financing for JDS, Nutrition 21; Neon Energy sponsors Idol winner’s tour; New Global makes ISG’s MoringaUP bars; and more news in brief.
      PubDate: Mon, 16 Nov 2015 00:02:23 -050
  • Google Platform Changes Spur Pharma Rethinking Of Search Engine Ads
    • Abstract: Widespread use of paid ads that display disease-specific website address differing significantly from destination hyperlink for branded product will end in January.
      PubDate: Mon, 16 Nov 2015 00:02:09 -050
  • PDUFA VI Might Adjust Establishment Fees; FDA Aims For Simplification
    • Abstract: User fees would need significant restructuring to make up revenue if establishment fees are eliminated, or even just changed, as part of reauthorization. As part of FDA-industry negotiations, several small working groups are expected to be created to deal with specific issues.
      PubDate: Mon, 16 Nov 2015 00:01:48 -050
  • ‘Double Check’ Acetaminophen Message Reaches Walmart
    • Abstract: The Acetaminophen Awareness Coalition says its efforts are “validated” by a study finding public awareness campaigns are critical to prevent accidental overdose of OTC drug ingredients. AAC will provide educational materials to almost 5,000 Walmart stores by the end of 2015, says CHPA.
      PubDate: Mon, 16 Nov 2015 00:01:23 -050
  • Sen. McCaskill Reaches Out To Retailers On Picamilon ‘In The Absence
           Of FDA Action’
    • Abstract: The Missouri Democrat tells retailers that FDA “hasn’t lifted a finger to inform the public or taken any action to remove” picamilon. Although an FDA official said in an affidavit to the Oregon AG that picamilon is not a dietary ingredient, the agency has not warned firms or consumers that it is unsafe.
      PubDate: Mon, 16 Nov 2015 00:01:16 -050
  • FDA Warns DTC Genetic Test Firms
    • Abstract: The warning letters are the first FDA sent since it carved out a de novo risk category for DTC carrier screening tests, clearing the path for 23andMe Inc. to relaunch its Personal Genome Service in October.
      PubDate: Mon, 16 Nov 2015 00:00:28 -050
  • Supplements Making Drug Claims Remain On FDA Warning Radar
    • Abstract: Supplements making claims of treating a disease represent a potential threat to consumers, says Bob Durkin, acting director of FDA’s Division of Dietary Supplement Programs.
      PubDate: Mon, 16 Nov 2015 00:00:07 -050
  • Weekly Trademark Review Nov. 3, 2015
    • Abstract: OTC drug, personal care product and nutritional supplement trademark filings compiled by “The Tan Sheet” from Official Gazette of the U.S. Patent and Trademark Office, Class 3 – Cosmetics and Cleaning Preps; and Class 5 – Pharmaceuticals.
      PubDate: Fri, 13 Nov 2015 00:00:02 -050
  • Mylan’s Perrigo Takeover Tender Top Of Mind At Investor Conference
    • Abstract: Mylan’s tender for a hostile takeover of Perrigo, amounting to roughly $27bn total, ends at 8 a.m. EDT on Nov. 13.
      PubDate: Thu, 12 Nov 2015 00:00:04 -050
  • FDA Compelled To Test ‘Natural’ Climate But Hedges On Planning
    • Abstract: FDA notes three citizen petitions asking the agency to define “natural” for use in food labeling and one asking it to prohibit the term on labels in addition to federal courts requesting administrative determinations. But a rulemaking might not be the outcome, and any decision will be a long time in coming.
      PubDate: Wed, 11 Nov 2015 00:05:01 -050
  • Regulatory Roundup: Drug Claims, Sen. McCaskill Contacts Retailers, Spiked
           Product Recall
    • Abstract: FDA warns Sound Healing Arts, Biomedic Labs and Orgen Nutraceuticals about drug claims on the firms’ websites or product labels; McCaskill slams FDA on picamilon; weight loss supplement marketer changes GMOs after recall.
      PubDate: Wed, 11 Nov 2015 00:00:03 -050
  • CRN Sees Voluntary Supplement Registry Bringing Regulatory Plus Retail
    • Abstract: While an industry-run registry would not conduct pre-market evaluations nor state that a product’s health claims and ingredients are compliant, retailers and other businesses selling supplements could see it as a seal of approval.
      PubDate: Tue, 10 Nov 2015 00:05:01 -050
  • Perrigo Paints Mylan As Shareholders’ Foe With Tender Winding Down
    • Abstract: Four days before the deadline for Mylan’s tender, Perrigo notes the SEC is investigating a Mylan land deal and a recent SEC rule change, prompted by Mylan’s actions to fend off a takeover attempt, requiring more transparency to shareholders when firms make deals that move their headquarters to other countries.
      PubDate: Tue, 10 Nov 2015 00:00:05 -050
  • Digital Media Deliver Results For Colgate Despite 23% Cut In Ad Spend
    • Abstract: Colgate cuts ad spending by 23% to $328m in its latest quarter but grows market share globally. The firm reports foreign currency exchange dragged down net sales 8.5% to $3.99bn.
      PubDate: Mon, 09 Nov 2015 00:05:01 -050
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-2015